Caribou Biosciences annual depreciation and amortization
2019
2020
2021
2022
2023
2024
2025
Caribou Biosciences Depreciation & Amortization Growth & History (CRBU)
Caribou Biosciences's depreciation and amortization was $3.6M for fiscal 2025.
View full Caribou Biosciences company overviewCaribou Biosciences annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $3.6M | −$282,000 | −7.18% |
| 2024 | 2024-12-31 | $3.9M | $402,000 | +11.40% |
| 2023 | 2023-12-31 | $3.5M | $1.9M | +117.32% |
| 2022 | 2022-12-31 | $1.6M | $638,000 | +64.84% |
| 2021 | 2021-12-31 | $984,000 | $84,000 | +9.33% |
| 2020 | 2020-12-31 | $900,000 | $149,000 | +19.84% |
| 2019 | 2019-12-31 | $751,000 | — | — |
Caribou Biosciences quarterly depreciation and amortization
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $625,000 | −$542,000 | −46.44% |
| Q1 2026 | 2026-03-31 | $649,000 | −$516,000 | −44.29% |
| Q4 2025 | 2025-12-31 | $682,000 | — | — |
| Q3 2025 | 2025-09-30 | $631,000 | −$546,000 | −46.39% |
| Q2 2025 | 2025-06-30 | $1.2M | $311,000 | +36.33% |
| Q1 2025 | 2025-03-31 | $1.2M | $455,000 | +64.08% |
| Q3 2024 | 2024-09-30 | $1.2M | −$402,000 | −25.46% |
| Q2 2024 | 2024-06-30 | $856,000 | $239,000 | +38.74% |
| Q1 2024 | 2024-03-31 | $710,000 | $121,000 | +20.54% |
| Q3 2023 | 2023-09-30 | $1.6M | $1.1M | +250.89% |
| Q2 2023 | 2023-06-30 | $617,000 | $259,000 | +72.35% |
| Q1 2023 | 2023-03-31 | $589,000 | $281,000 | +91.23% |
| Q3 2022 | 2022-09-30 | $450,000 | $190,000 | +73.08% |
| Q2 2022 | 2022-06-30 | $358,000 | $128,000 | +55.65% |
| Q1 2022 | 2022-03-31 | $308,000 | $87,000 | +39.37% |
| Q3 2021 | 2021-09-30 | $260,000 | $34,000 | +15.04% |
| Q2 2021 | 2021-06-30 | $230,000 | — | — |
| Q1 2021 | 2021-03-31 | $221,000 | — | — |
| Q3 2020 | 2020-09-30 | $226,000 | — | — |
Caribou Biosciences depreciation and amortization trends
Over the last five fiscal years, Caribou Biosciences's depreciation and amortization increased from $900,000 to $3.6M, a change of $2.7M. The latest reported quarter, Q2 2026, shows $625,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Caribou Biosciences source filings ↗